Form4insider filings, from the source

SEC Form 4 · accession 0000905148-16-001666

REATA PHARMACEUTICALS INC · RETA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
R Kent McGaughy Jr.
Director · 10% Owner
Period of report
Jun 6, 2016
Accepted (ET)
Jun 8, 2016 · 2:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001358762

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Class A common stockF1,F6,F7Jun 6, 2016P20,000$17.5596A390,557ISee footnote
Class A common stockF2,F6,F7Jun 7, 2016P4,220$17.6209A394,777ISee footnote
Class A common stockF3,F7holding———4,591IBy Lagos Trust
Class A common stockF4,F7holding———280IBy Traweek Children's Trust
Class A common stockF5,F7holding———2,739ISee footnote
Class A common stockholding———25,004D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses